AKYA

Akoya Biosciences
AKYA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
-
EV
-
Shares Outstanding
-
Beta
-
Industry
Medical - Instruments & Supplies

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
Number of Analysts
1
P/E 2025E
-
P/Revenue 2025E
0.82x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Akoya Biosciences, Inc.

gainify
AKYA

Akoya Biosciences, Inc.

AKYA

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, ...

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

McKelligon, Brian

Employees

IPO Date

2021-04-16

Headquarters

100 Campus Drive, 6th Floor, Marlborough, Massachusetts, 01752, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.